ProPhase Labs Inc. (DE) (PRPH)

Business: ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States.

IPO Date: 16-Jan-1997

Chairman & CEO: Mr. Ted William Karkus

Chief Accounting Officer: Ms. Monica Brady

Listing: NASDAQ: PRPH

Country: United States

Headquarters: Garden City, NY

Website: https://www.prophaselabs.com

Market cap: $178.65 Mln

Revenue (TTM): $111.30 Mln

Earnings (TTM): $17.71 Mln

Cash: $29.35 Mln

Total Debt: $12.80 Mln

Insider's Holding: 19.02%

Liquidity: Low

52 Week range: $4.76 - 15.24

Shares outstanding: 15,685,100

10 Years Aggregate:

• CFO: $-33.79 Mln
• EBITDA: $18.24 Mln
• Net Profit: $26.11 Mln